Granisetron
Sancuso, Sustol (granisetron) is a small molecule pharmaceutical. Granisetron was first approved as Sancuso on 2008-09-12. It has been approved in Europe to treat neoplasms and vomiting. Granisetron hydrochloride's patents are valid until 2025-01-22 (FDA).
Trade Name | Sancuso |
---|---|
Common Name | Granisetron |
Indication | neoplasms, vomiting |
Drug Class | Serotonin 5-HT3 antagonists |